M. Kurjak et al., PRESYNAPTIC MODULATION BY VIP, SECRETIN AND ISOPROTERENOL OF SOMATOSTATIN RELEASE FROM ENRICHED ENTERIC SYNAPTOSOMES - ROLE OF CAMP, European journal of pharmacology, 314(1-2), 1996, pp. 165-173
The release of somatostatin-like immunoreactivity was studied in isola
ted enteric synaptosomes. A significant release of somatostatinlike im
munoreactivity was observed in the presence of vasoactive intestinal p
olypeptide (VIP) (10(-6) M: 53.0 +/- 12.4 pg/mg, basal: 14.3 +/- 1.7 p
g/mg, n = 5, P < 0.05), secretin(10(-6) M: 56.1 +/- 3.8 pg/mg, basal:
25.8 +/- 1.6 pg/mg, n = 6, P < 0.01) and isoproterenol (10(-5) M: 54.0
+/- 13.4 pg/mg, basal: 20.0 +/- 3.4 pg/mg, n = 8, P < 0.05). Forskoli
n, an unspecific activator of the adenylate cyclase, caused a signific
ant release of somatostatin-like immunoreactivity (10(-6) M: 57.3 +/-
13.2 pg/mg, basal: 30.0 +/- 5.8 pg/mg, n = 13, P < 0.01) which was fur
ther augmented in the presence of the phosphodiesterase inhibitor 3-is
obutyl-1-methylxanthine (IBMX 10(-4) M) (77.0 +/- 17.8 pg/mg, n = 13,
P < 0.01). 3-Isobutyl-1-methylxanthine and N-6,2'-O-dibutyryladenosine
-3',5'-cyclic monophosphate mimicked the effect of forskolin and VIP.
The release of somatostatin was paralleled by an increase of cAMP immu
noreactivity in the presence of VIP (10(-6) M: 37.1 +/- 9.4 pmol/mg, b
asal: 19.8 +/- 4.2 pmol/mg, n = 10, P < 0.05), isoproterenol (10(-5) M
: 42.4 +/- 9.8 pmol/mg, basal: 16.7 +/- 2.4 pmol/mg, n = 12, P < 0.01)
and forskolin (10(-6) M: 47.1 +/- 12.4 pmol/mg, basal: 19.8 +/- 4.2 p
mol/mg, n = 10, P < 0.01). The effect of nitric oxide (NO) which acts
as an inhibitory neurotransmitter in the enteric nervous system was st
udied. NO is known to activate soluble guanylate cyclase to induce tra
nsmitter release. The NO-generating compound sodium nitroprusside and
bromoguanosine-3',5'-cyclic monophosphate (8-Br-cGMP) had no effect on
the release of somatostatin-like immunoreactivity. These data demonst
rate the stimulatory effect of VIP, secretin and isoproterenol on rele
ase of somatostatin-like immunoreactivity from enteric synaptosomes, w
hich is presumably mediated by cAMP-dependent mechanisms. cGMP-depende
nt mechanisms seem to be of minor relevance.